Private Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$323K Buy
279
+31
+13% +$36.6K 0.07% 83
2026
Q2
$297K Buy
248
+59
+31% +$60.3K 0.07% 86
2026
Q1
$174K Sell
189
-7
-4% -$7.1K 0.05% 90
2025
Q4
$211K Sell
196
-1
-0.5% -$956 0.06% 85
2025
Q3
$150K Buy
197
+7
+4% +$5.21K 0.04% 102
2025
Q2
$148K Buy
190
+29
+18% +$22.5K 0.05% 99
2025
Q1
$133K Buy
161
+26
+19% +$21.6K 0.05% 98
2024
Q4
$104K Sell
135
-18
-12% -$14.9K 0.04% 110
2024
Q3
$136K Sell
153
-2
-1% -$1.8K 0.05% 88
2024
Q2
$140K Sell
155
-17
-10% -$13.6K 0.06% 88
2024
Q1
$134K Sell
172
-2
-1% -$1.42K 0.06% 82
2023
Q4
$101K Buy
+174
New +$102K 0.05% 98

Other funds holding LLY

Private Wealth Management Group's LLY Position: Q3 2026 in Review

Private Wealth Management Group increased its Eli Lilly (LLY) stake by 13% in Q3 2026, buying an estimated $36.6K and bringing the position to 279 shares worth $323K. The position accounts for 0.07% of the portfolio, ranked #83.

Private Wealth Management Group first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Private Wealth Management Group held 279 shares of Eli Lilly worth $323K as of Q3 2026.
  • Private Wealth Management Group bought 31 Eli Lilly shares in Q3 2026, an estimated $36.6K.
  • Eli Lilly made up 0.07% of Private Wealth Management Group's portfolio in Q3 2026, its #83 holding.
  • Private Wealth Management Group first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.